— Know what they know.
Not Investment Advice

2348.HK HKSE

Dawnrays Pharmaceutical (Holdings) Limited
1W: +0.0% 1M: -2.5% 3M: -3.0% YTD: -18.5% 1Y: -27.1% 3Y: -9.3% 5Y: -29.2%
HK$0.97 ($0.12)
-0.01 (-0.51%)
 
Weekly Expected Move ±2.0%
HK$1 HK$1 HK$1 HK$1 HK$1
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 46 · HK$1.5B mcap · 489M float · 0.028% daily turnover

📊 Key Metrics

TTM
HK$2B
Revenue
-5.5% YoY
HK$408M
Net Income
-59.5% YoY
HK$494M
Free Cash Flow
+58.7% YoY
51.4%
Gross Margin
21.4%
Op. Margin
22.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE12.2%
ROA10.1%
ROIC18.1%

Valuation

P/E5.4
P/B0.4
EV/EBITDA0.0

Leverage

Debt/Equity0.00
Current Ratio5.38
Interest Cov.531.0x

Quality Scores

Piotroski F5/9
Altman Z—
Beneish M-2.84

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms